Literature DB >> 7196972

Cyst formation in rat kidney induced by cis-platinum administration.

D C Dobyan, D Hill, T Lewis, R E Bulger.   

Abstract

The long-term pathologic effects of the antitumor drug, cis-diamminedichloroplatinum II (CP) on the structure of the rat kidney were investigated. Light microscopy and transmission and scanning electron microscopy were used to characterize the morphologic changes 2 weeks, 4 weeks, and 6 months after the intraperitoneal injection of CP to rats. At all time intervals examined, the S3 segment of the proximal tubule located in the outer stripe of the medulla showed the most consistent pattern of injury. Two weeks after CP, the proximal tubules located in the outer stripe region as well as in the medullary rays were widely dilated and lined by low-lying epithelial cells, many of which contained large atypical nuclei. Many tubules still showed evidence of necrosis, whereas other tubules appeared to be undergoing atrophic changes. After 4 weeks, proximal tubular dilation continued resulting in the formation of numerous microcysts in the region of the outer stripe. These changes appeared to progress, and after 6 months large cysts (mean diameter 2152 +/- 1241 micrometer) were identified which involved the entire outer stripe, with many of these cysts extending to the subcapsular cortex. The kidneys at this time period showed a pattern of chronic renal injury in the outer stripe, and this damage was now also observed in the cortex. In several animals, small foci of abnormal foam cells surrounded by a basal lamina could be identified. We conclude that CP has a pronounced long-term effect and causes cyst formation in the rat kidney.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196972

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Cyst formation in metanephric organ culture induced by cis-dichlorodiammineplatinum (II).

Authors:  E D Avner; W E Sweeney; D Ellis
Journal:  Experientia       Date:  1983-01-15

2.  Abnormal lipid and fatty acid compositions of kidneys from mice with polycystic kidney disease.

Authors:  H M Aukema; T Yamaguchi; H Takahashi; B Celi; B J Holub
Journal:  Lipids       Date:  1992-06       Impact factor: 1.880

3.  Long-term studies of cisplatin-induced reductions in porcine renal functional reserve.

Authors:  M E Robbins; T B Bywaters; R S Jaenke; J W Hopewell; L M Matheson; P Tothill; E Whitehouse
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Basement membrane antigens in renal polycystic disease.

Authors:  F A Carone; H Makino; Y S Kanwar
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

5.  A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat.

Authors:  I Mahmood; D H Waters
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

6.  Serum immunosuppressive acidic protein in haemodialysis patients with and without acquired cystic disease of the kidney.

Authors:  I Sasagawa; T Nakada; Y Kubota; T Sawamura
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

7.  Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics.

Authors:  Takeki Uehara; Jyoji Yamate; Mikinori Torii; Toshiyuki Maruyama
Journal:  J Toxicol Pathol       Date:  2011-06-30       Impact factor: 1.628

8.  Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.

Authors:  Annegien T Kenter; Eveline Rentmeester; Job van Riet; Ruben Boers; Joachim Boers; Mehrnaz Ghazvini; Vanessa J Xavier; Geert J L H van Leenders; Paul C M S Verhagen; Marjan E van Til; Bert Eussen; Monique Losekoot; Annelies de Klein; Dorien J M Peters; Wilfred F J van IJcken; Harmen J G van de Werken; Robert Zietse; Ewout J Hoorn; Gert Jansen; Joost H Gribnau
Journal:  Stem Cells Transl Med       Date:  2020-03-12       Impact factor: 6.940

9.  A possible critical dosing period of p-cumylphenol for development of cystic kidneys in rat neonates.

Authors:  Tomomi Nakazawa; Yuko Yamaguchi; Yachiyo Fukunaga; Kazutoshi Tamura
Journal:  J Toxicol Pathol       Date:  2021-09-24       Impact factor: 1.628

10.  The urine urokinase concentration in end stage renal disease with acquired renal cyst.

Authors:  S Y Hong; D H Yang; B H Lee; E K Ki; K H Chung
Journal:  Korean J Intern Med       Date:  1991-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.